Sherpa Capital Leads Nearly $23M Series B Round In Chinese Radiology Imaging Firm

Nanovision Technology, a high-tech enterprise focused on high-speed and high-precision radiology imaging, has raised RMB160 million (US$22.93 million) in a series B round of financing led by Sherpa Venture Capital.

Proceeds of this round will be used for commercialization of products.

Nanovison was founded in March 2014 to focus on static CT, x-ray CMOS detectors and x-ray imaging software which can be widely used in medical, industrial, security and other fields.

"By the end of 2017, China had only 14.3 CT devices per million people, while Japan had 92.6 CT devices per million people and the United States has 32.2 devices per million people. Obviously, there is still much room for development in the Chinese market," said Li Yunxiang, CEO of Nanovision.

The company has raised a total of RMB300 million including the latest round, from investors such as Legend Capital, Sherpa Capital and Hillhouse Capital

(This article is translated from vcbeat.top. You can see the original article in Chinese here.)

Related News